30.09.2022 22:30:00
|
Information on the total number of voting rights and shares
REGULATED INFORMATION
Mont-Saint-Guibert (Belgium), September 30, 2022, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the belowinformation following the issue of new shares.
- Share capital: EUR 4,440,069.16
- Total number of securities carrying voting rights: 25,846,279 (all ordinary shares)
- Total number of voting rights (= denominator): 25,846,279 (all relating to ordinary shares)
- Number of rights to subscribe to securities carrying voting rights not yet issued:
-
- 55 "2016 ESOP Warrants” issued on November 3, 2016, entitling their holders to subscribe to a total number of 27,500 securities carrying voting rights (all ordinary shares);
- 100 "2018 ESOP Warrants” issued on December 12, 2018, entitling their holders to subscribe to a total number of 50,000 securities carrying voting rights (all ordinary shares);
- 460,500 "2020 ESOP Warrants” issued on February 21, 2020, entitling their holders to subscribe to a total number of 460,500 securities carrying voting rights (all ordinary shares); and
- 1,378,125 "2021 ESOP Warrants” issued on September 8, 2021, entitling their holders to subscribe to a total number of 1,378,125 securities carrying voting rights (all ordinary shares).
*
* *
For further information, please contact:
Nyxoah
Jeremy Feffer, VP IR and Corporate Communications
jeremy.feffer@nyxoah.com
+1 917 749 1494
Attachment
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Nyxoah S.A. Registered Shsmehr Nachrichten
13.12.24 |
EQS-News: Nyxoah gibt die Markteinführung der innovativen Genio®-Therapie in England bekannt (EQS Group) | |
13.12.24 |
EQS-News: Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England (EQS Group) | |
06.11.24 |
EQS-News: Nyxoah gibt Finanzergebnisse für das dritte Quartal 2024 bekannt und informiert über die Unternehmensentwicklung (EQS Group) | |
06.11.24 |
EQS-News: Nyxoah Reports Third Quarter Financial and Operating Results (EQS Group) | |
05.11.24 |
EQS-News: Nyxoah kündigt Teilnahme an der Münchner Kapitalmarkt Konferenz und dem Deutschen Eigenkapitalforum an (EQS Group) | |
05.11.24 |
Ausblick: Nyxoah mit Zahlen zum abgelaufenen Quartal (finanzen.net) | |
21.10.24 |
Erste Schätzungen: Nyxoah öffnet die Bücher zum abgelaufenen Quartal (finanzen.net) | |
08.10.24 |
EQS-News: Nyxoah Raises $27 Million through its At-the-Market Offering (EQS Group) |